Bio-Key Intl Inc (BKYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,869 | -1,904 | -737 | -4,301 | -2,916 |
| Depreciation Amortization | 590 | 410 | 205 | 777 | 495 |
| Income taxes - deferred | N/A | N/A | N/A | -23 | N/A |
| Accounts receivable | 9 | -15 | -85 | 856 | -399 |
| Accounts payable and accrued liabilities | -162 | 71 | -260 | -503 | 249 |
| Other Working Capital | -617 | -154 | -421 | 788 | -43 |
| Other Operating Activity | 210 | -124 | 462 | -508 | 214 |
| Operating Cash Flow | $-2,838 | $-1,715 | $-835 | $-2,914 | $-2,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -6 | -5 | -13 | -23 |
| Investing Cash Flow | $-7 | $-6 | $-5 | $-13 | $-23 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,000 | N/A |
| Debt Repayment | -109 | -72 | -35 | -150 | -102 |
| Common Stock Issued | 3,813 | 3,814 | 3,813 | 1,912 | 2,000 |
| Other Financing Activity | 752 | -249 | -249 | -935 | 1,762 |
| Financing Cash Flow | $4,456 | $3,494 | $3,529 | $2,827 | $3,660 |
| Exchange Rate Effect | -8 | 66 | 7 | 27 | 52 |
| Beginning Cash Position | 438 | 438 | 438 | 511 | 511 |
| End Cash Position | 2,040 | 2,275 | 3,134 | 438 | 1,801 |
| Net Cash Flow | $1,602 | $1,838 | $2,696 | $-74 | $1,290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,838 | -1,715 | -835 | -2,914 | -2,400 |
| Capital Expenditure | -7 | -6 | -5 | -13 | -23 |
| Free Cash Flow | -2,846 | -1,721 | -840 | -2,927 | -2,423 |